Status:
COMPLETED
New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques
Lead Sponsor:
Mayo Clinic
Conditions:
Carotid Artery Plaque
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The researchers are trying to determine if the characterization of "vulnerable" carotid artery plaques can be accomplished with ultrasound-based methods that look for vessels in the plaque and measure...
Detailed Description
All participants will receive a one time Carotid contrast-enhanced Ultrasound (CEUS) examination that may take 30-60 minutes. Follow up calls will be made to the Participants at 6, 12 ,24 and 36 month...
Eligibility Criteria
Inclusion
- Subject has carotid plaque with \> 50% stenosis
- Subject is able to understand the study procedure and provide informed consent
Exclusion
- Subject is pregnant or breast feeding
- Subject is unable to provide informed consent
- Subject has contraindication to the use of the Lumason contrast agent.
Key Trial Info
Start Date :
November 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03335033
Start Date
November 15 2017
End Date
January 30 2022
Last Update
November 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905